Common Contracts
2 similar Registration Rights Agreement contracts by Cas Medical Systems Inc, Hana Biosciences Inc
CAS MEDICAL SYSTEMS, INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 13th, 2011 • Cas Medical Systems Inc • Surgical & medical instruments & apparatus • New York
This Registration Rights Agreement (this “Agreement”), dated June 9, 2011, among CAS Medical Systems, Inc., a Delaware corporation (the “Company”), and the purchasers signatory hereto (each, a “Purchaser”, and collectively, the “Purchasers”), is entered into pursuant to that certain Investment Agreement, dated June 8, 2011, by and between the Company and the Purchasers (the “Investment Agreement”), providing for the Company’s issuance and sale of (a) Series A Convertible Preferred Stock (the “Series A Preferred Stock”), which will be, upon issuance, convertible into authorized but unissued shares (“Series A Preferred Conversion Shares”) of common stock, par value $0.004 per share, of the Company (the “Common Stock”), and will have the terms set forth in the Certificate of Designation for such Series A Preferred Stock (the “Series A Preferred Certificate of Designation”) and (b) Series A Exchangeable Preferred Stock (the “Series A Exchangeable Preferred Stock”), which Series A Exchangea
HANA BIOSCIENCES, INC. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 11th, 2010 • Hana Biosciences Inc • Pharmaceutical preparations • Delaware
This Registration Rights Agreement (this “Agreement”), dated June 7, 2010, among Hana Biosciences, Inc., a Delaware corporation (the “Company”), and the purchasers signatory hereto (each, a “Purchaser”, and collectively, the “Purchasers”), is entered into pursuant to that certain Investment Agreement, dated June 7, 2010, by and between the Company and the Purchasers (the “Investment Agreement”), providing for the Company’s issuance and sale of (a) Series A-1 Convertible Preferred Stock (the “Series A-1 Preferred Shares”), which will be, upon issuance, convertible into authorized but unissued shares (“Series A-1 Conversion Shares”) of common stock, par value $0.001 per share, of the Company (the “Common Stock”), and will have the terms set forth in the Certificate of Designations for such Series A-1 Preferred Shares (the “Series A-1 Certificate of Designation”) and (b) Series A-2 Convertible Preferred Stock (the “Series A-2 Preferred Shares”, the Series A-1 Preferred Shares and the Seri
